World Menopause Day is held every year on the 18th October. The purpose of the day is to raise awareness of the menopause and the support options available for improving health and wellbeing. We encourage professionals and women to participate in this global awareness raising campaign by printing and sharing these materials, organising events to engage their communities, and sharing World Menopause Day social media posts. 

The theme for World Menopause Day 2022 is Cognition and Mood

The October print issue of Climacteric includes Brain fog in menopause: a health-care professional’s guide for decision-making and counseling on cognition: IMS White Paper 2022 Brain fog in menopause1.26 MB.

The paper is also available via Climacteric online with free access here. 

From the paper:

Introduction

Cognitive complaints are frequent in midlife women and are associated with decreased quality of life [1]. These cognitive complaints are reliably validated and documented across the menopause transition (MT). Basic and clinical studies show a role for estradiol (E2) in mediating menopause-related changes in cognition [2]. In addition, menopause symptoms, including vasomotor symptoms (VMS), sleep disturbances and mood changes contribute to cognitive difficulties at midlife [3], but there are critical gaps in the data as to whether this period of cognitive dysfunction predicts dementia risk, and whether menopausal hormone therapy (MHT) is protective against late-onset dementia or increases the risk. The theme for the 2022 World Menopause Day is Cognition and Mood, and the goal of this International Menopause Society-commissioned White Paper on cognition is to provide menopause practitioners with an overview of data informing clinical care of menopausal women and a framework for clinical counseling and decision-making for their patients.

The key sections focus on questions commonly raised in clinical care and include the following:

• What do we mean by cognitive function and brain fog?
• How does cognitive function change in menopause?
• What menopause-related factors appear to influence cognition?
• What role does MHT play?
• What other modifiable risk factors influence cognition at midlife?
• What are the generally agreed upon recommendations for optimizing brain health that clinicians can share with their patients? 

Read full paper here

World Menopause Day is held every year on the 18th October. The purpose of the day is to raise awareness of the menopause and the support options available for improving health and wellbeing. We encourage professionals and women to participate in this global awareness raising campaign by printing and sharing these materials, organising events to engage their communities, and sharing World Menopause Day social media posts. 

The theme for World Menopause Day 2021 is Bone Health.

The October print issue of Climacteric includes the Update on bone health: the IMS White Paper. The paper is also available via Climacteric online with free access here. 

Osteoporosis and associated fractures present a major challenge in improving global health outcomes. Key clinical aspects are the definition of osteoporosis and associated fractures, fracture risk prediction, stratification of risk of fracture, intervention thresholds and the most appropriate intervention based on integration of aforementioned. Correct understanding and application of these concepts are essential to stem the increasing tide of fragility fractures associated with an aging population. The role of muscle strength and function, sarcopenia, and the newly emerging concept of osteosarcopenia in maintaining bone health are discussed in detail.

The International Menopause Society has commissioned two experts at the forefront of their specialty to define the state of the art in the understanding of this condition, to advise on practical management strategies and to propose future research strategies.

Update on bone health: the International Menopause Society White Paper 2021.

The Board of the International Menopause Society (IMS) has decided to focus on bone health for World Menopause Day 2021. Osteoporosis and associated fractures are the most common chronic metabolic bone disease and represent a major global health problem, contributing to 8.9 million fractures worldwide on an annual basis [1]. Worldwide, there are marked variations in the rates of hip fracture and major osteoporotic fractures [2]. Fractures associated with osteoporosis cause not only increased morbidity but also an increased mortality [3]. A special issue of Climacteric dealing in great depth with all aspects of bone health will appear later this year. The first part of the present paper deals with demystifying key clinical aspects of osteoporosis, namely definition, fracture risk prediction, stratification of risk, intervention thresholds and the integration of these factors into clinical practice. The second part of the paper deals with the emerging recognition of the role of muscle strength and function in maintaining bone health.

You can access the White paper here when published.  

AMS Information Sheets - for Health Professionals

The AMS has recently updated the Information Sheet Calcium supplements and also has Osteoporosis.

AMS Fact Sheets - for Patients

The AMS has the patient Fact Sheets Decreasing the risk of falls and fractures before, during and after menopause

Decreasing the risk of falls and fractures before, during and after menopause67.29 KB

World Menopause Day is held every year on the 18th October. The purpose of the day is to raise awareness of the menopause and the support options available for improving health and wellbeing. We encourage professionals and women to participate in this global awareness raising campaign by printing and sharing these materials, organising events to engage their communities, and sharing World Menopause Day social media posts. 

The theme for World Menopause Day 2020 is Premature Ovarian Insufficiency (POI).

The October print issue of Climacteric includes the White Paper. The paper is also available via Climacteric online with free access. 

Premature Ovarian Insufficiency: an International Menopause Society White Paper

The aim of this White paper on Premature Ovarian Insufficiency (POI) is to provide the latest information regarding this distressing condition. The impact of POI has far-reaching consequences due to its impact on general, psychological and sexual quality of life, fertility prospects and long-term bone, cardiovascular and cognitive health.

The International Menopause Society has commissioned a number of experts at the forefront of their specialty to define the state of the art in the understanding of this condition, to advise on practical management strategies and to propose future research strategies.

You can access the White paper here Premature Ovarian Insufficiency: an International Menopause Society White Paper2.30 MB        

AMS Information Sheets - for Health Professionals

The AMS has recently updated the Information Sheets Premature Ovarian Insufficiency and Early Menopause due to Chemotherapy and Radiotherapy.

AMS Fact Sheets - for Patients

The AMS has also recently updated the patient Fact Sheets Menopause before 40 and Spontaneous POI and Early Menopause – Chemotherapy and Radiotherapy.

Patient Booklet - Testosterone and Women 

Health Professionals - International consensus on testosterone treatment for women and Case Study

Media Release - World Menopause Day 2019